TherOx Aqueous Oxygen System Offers Coronary, Cerebral Applications
This article was originally published in The Gray Sheet
Executive Summary
TherOx is aiming to submit a premarket approval application for the aqueous oxygen system in the first quarter of 2000. The product is used to improve microvascular blood flow and heart function in acute myocardial infarction patients.
You may also be interested in...
PMA Panel Asks TherOx For New Data On Cath-Lab-Based Oxygen Therapy
FDA's Circulatory System Devices advisory panel is encouraging TherOx to sponsor a new clinical trial of its SSO2 SuperSaturated Oxygen Therapy Downstream system to demonstrate the therapy improves clinical outcomes in heart attack patients
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.